Inventor · disambiguated record
Thomas Kirkland
Also filed as: KIRKLAND THOMAS · KIRKLAND THOMAS A · KIRKLAND THOMAS ANDREW
58 granted patents·29 pending applications·275 citations·filing 2006–2025
98Inventor score
Top patents by PatentIndex Score
87 records- 0198US10107800B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2017·Granted Oct 23, 2018·14 cites·18 claims
- 0298US9797889B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2014·Granted Oct 24, 2017·33 cites·12 claims
- 0397US11493504B2Activation of bioluminescene by structural complementationPROMEGA CORP·Filed 2020·Granted Nov 8, 2022·4 cites·13 claims
- 0497US9797890B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2014·Granted Oct 24, 2017·24 cites·13 claims
- 0596US10648971B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted May 12, 2020·6 cites·7 claims
- 0696US10288605B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted May 14, 2019·10 cites·18 claims
- 0795US9869670B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2016·Granted Jan 16, 2018·12 cites·25 claims
- 0894US10184936B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2018·Granted Jan 22, 2019·5 cites·3 claims
- 0994US10067149B2Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transferPROMEGA CORP·Filed 2013·Granted Sep 4, 2018·14 cites·18 claims
- 1093US10308975B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2018·Granted Jun 4, 2019·4 cites·16 claims
- 1193US10000500B2Coelenterazine analoguesPROMEGA CORP·Filed 2017·Granted Jun 19, 2018·6 cites·20 claims
- 1293US9056885B2Carboxy X rhodamine analogsPROMEGA CORP·Filed 2012·Granted Jun 16, 2015·13 cites·28 claims
- 1392US12366572B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2024·Granted Jul 22, 2025·0 cites·5 claims
- 1492US10024862B2Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transferPROMEGA CORP·Filed 2013·Granted Jul 17, 2018·13 cites·26 claims
- 1592US9924073B2Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereofPROMEGA CORP·Filed 2017·Granted Mar 20, 2018·5 cites·10 claims
- 1692US9315509B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 1792US7737145B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseESTRELLITA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·32 cites·10 claims
- 1891US10428075B2Coelenterazine analoguesPROMEGA CORP·Filed 2018·Granted Oct 1, 2019·4 cites·14 claims
- 1990US11267819B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 2090US10618907B2Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elementsPROMEGA CORP·Filed 2016·Granted Apr 14, 2020·5 cites·10 claims
- 2190US8569303B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseARNAIZ DAMIAN O·Filed 2010·Granted Oct 29, 2013·19 cites·12 claims
- 2289US2025045806A1Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2024·Application pending·0 cites
- 2388US10280447B2Substituted imidazo[1,2-A]pyrazines tethered to energy acceptorsPROMEGA CORP·Filed 2017·Granted May 7, 2019·4 cites·20 claims
- 2488US2025296935A1Diamine Derivatives as Inhibitors of Leukotriene A4 HydrolaseCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 2587US11072812B2Substrates for covalent tethering of proteins to functional groups or solid surfacesPROMEGA CORP·Filed 2014·Granted Jul 27, 2021·3 cites·16 claims
- 2687US10571471B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2016·Granted Feb 25, 2020·2 cites·14 claims
- 2787US10400264B25,5-disubstituted luciferins and their use in luciferase-based assaysPROMEGA CORP·Filed 2017·Granted Sep 3, 2019·4 cites·30 claims
- 2887US9551705B2Compositions and methods for capture of cellular targets of bioactive agentsPROMEGA CORP·Filed 2013·Granted Jan 24, 2017·6 cites·16 claims
- 2987US2025340923A1SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATESPROMEGA CORP·Filed 2025·Application pending·0 cites
- 3086US12367513B2Activation of bioluminescence by structural complementationPROMEGA CORP·Filed 2022·Granted Jul 22, 2025·0 cites·13 claims
- 3185US10168323B2Compositions and methods for capture of cellular targets of bioactive agentsPROMEGA CORP·Filed 2014·Granted Jan 1, 2019·5 cites·5 claims
- 3284US11899021B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2023·Granted Feb 13, 2024·0 cites·11 claims
- 3384US9676997B2Compositions and methods for stabilizing luminogenic substratesPROMEGA CORP·Filed 2015·Granted Jun 13, 2017·3 cites·17 claims
- 3482US11740249B2Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transferPROMEGA CORP·Filed 2018·Granted Aug 29, 2023·1 cites·23 claims
- 3581US12391973B2Substituted imidazo[1,2-α]pyrazines as luciferase substratesPROMEGA CORP·Filed 2023·Granted Aug 19, 2025·0 cites·8 claims
- 3681US12173009B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 3781US2023417778A1Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transferPROMEGA CORP·Filed 2023·Application pending·0 cites
- 3878US10577370B2Cell impermeable coelenterazine analoguesPROMEGA CORP·Filed 2017·Granted Mar 3, 2020·1 cites·25 claims
- 3978US2024295548A1Photoaffinity probesPROMEGA CORP·Filed 2024·Application pending·0 cites
- 4077US11781168B2Process for preparing substituted imidazo[1,2-α]pyrazinesPROMEGA CORP·Filed 2021·Granted Oct 10, 2023·0 cites·12 claims
- 4176US11567083B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2020·Granted Jan 31, 2023·0 cites·13 claims
- 4276US10139400B2Carboxy X rhodamine analogsPROMEGA CORP·Filed 2015·Granted Nov 27, 2018·1 cites·19 claims
- 4375US10669568B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2019·Granted Jun 2, 2020·0 cites·13 claims
- 4474US12221648B2Substrates for covalent tethering of proteins to functional groups or solid surfacesPROMEGA CORP·Filed 2021·Granted Feb 11, 2025·0 cites·14 claims
- 4574US10215751B2Carboxy X rhodamine analogsPROMEGA CORP·Filed 2016·Granted Feb 26, 2019·1 cites·20 claims
- 4674US2024343906A1Poloxamer-stabilized reagentsPROMEGA CORP·Filed 2024·Application pending·0 cites
- 4773US10928400B2Luciferase-based thermal shift assaysPROMEGA CORP·Filed 2020·Granted Feb 23, 2021·0 cites·9 claims
- 4873US2024059697A1Coelenterazine analoguesPROMEGA CORP·Filed 2023·Application pending·0 cites
- 4972US11534504B2Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereofPROMEGA CORP·Filed 2019·Granted Dec 27, 2022·0 cites·17 claims
- 5072US11015216B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2020·Granted May 25, 2021·0 cites·8 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Kirkland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →